Novel therapeutic targets of metformin: metabolic syndrome and cardiovascular disease.
about
Dysfunctional adipose tissue and low-grade inflammation in the management of the metabolic syndrome: current practices and future advancesRole of biomarkers in cardiac structure phenotyping in heart failure with preserved ejection fraction: critical appraisal and practical use.Metformin - a Future Therapy for Neurodegenerative Diseases : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.Metabolomic determination of pathogenesis of late-onset preeclampsia.Metformin attenuates angiotensin II-induced TGFβ1 expression by targeting hepatocyte nuclear factor-4-α.
P2860
Novel therapeutic targets of metformin: metabolic syndrome and cardiovascular disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Novel therapeutic targets of metformin: metabolic syndrome and cardiovascular disease.
@en
type
label
Novel therapeutic targets of metformin: metabolic syndrome and cardiovascular disease.
@en
prefLabel
Novel therapeutic targets of metformin: metabolic syndrome and cardiovascular disease.
@en
P2860
P50
P1476
Novel therapeutic targets of metformin: metabolic syndrome and cardiovascular disease.
@en
P2093
Francisco Sampaio
Vasco Gama
P2860
P304
P356
10.1517/14728222.2015.1025051
P407
P577
2015-03-11T00:00:00Z